Atrioventricular nodal reentrant tachycardia. Other forms of heart disease
Conditions
Interventions
Intervention 1: The patients were randomly divided into two groups: The sedation group received sedatives, including Midazolam (tranquilizer and soporific) at a dose of 0.03mg/kg every half hour, Fent
Treatment - Drugs
The patients were randomly divided into two groups: The sedation group received sedatives, including Midazolam (tranquilizer and soporific) at a dose of 0.03mg/kg every half hour, Fentanyl (opiate ana
The control group received no drugs for sedation.
Sponsors
Iran Cardiovascular Research Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Being diagnosed with AVNRT according to physical examination and ECG and thus being candidated for EPS and ablation; having only one type of arrhythmia; giving consent to treatment with sedatives. Exclusion criteria: Not giving consent to treatment with sedatives; having two types of arrhythmia; having already undergone ablation; having a history of receiving anti-convulsive and psychotropic drugs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence of arrhythmia. Timepoint: Three months. Method of measurement: History - physical exam - ECG. | — |
Secondary
| Measure | Time frame |
|---|---|
| . Timepoint: . Method of measurement: . | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMrs. Azam Forghaniyan
Shaheed Rajaei Cardiovascular, Medical and Research Center
Outcome results
None listed